CANbridge Pharmaceuticals Inc. (HKG:1228)
Hong Kong · Delayed Price · Currency is HKD 2.620
+0.030 (1.16%)
At close: Mar 27, 2026
CANbridge Pharmaceuticals Market Cap
CANbridge Pharmaceuticals has a market cap or net worth of 1.56 billion as of March 27, 2026. Its market cap has increased by 1,906.63% in one year.
Market Cap
1.56B
Enterprise Value
1.60B
Revenue
68.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.62
Market Cap Chart
Since December 10, 2021, CANbridge Pharmaceuticals's market cap has decreased from 3.78B to 1.56B, a decrease of -58.68%. That is a compound annual growth rate of -18.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 1.56B | 19.23% |
| Dec 31, 2025 | 1.31B | 2,215.73% |
| Dec 31, 2024 | 56.50M | -86.56% |
| Dec 29, 2023 | 420.31M | -59.56% |
| Dec 30, 2022 | 1.04B | -72.41% |
| Dec 31, 2021 | 3.77B | -0.22% |
| Dec 10, 2021 | 3.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Frontage Holdings | 2.31B |
| Mabpharm | 2.31B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.91B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.87B |
| HighTide Therapeutics | 1.74B |
| Cutia Therapeutics | 1.70B |
| Immunotech Biopharm | 1.66B |
| Zhaoke Ophthalmology | 1.61B |